In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...